Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model

Journal of Molecular and Cellular Cardiology

Volumn 46, Issue 1, 2009, Pages 67-74

  Batchu, S N ^a   Law, E ^a   Brocks, D R ^a   Falck, J R ^b   Seubert, J M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Epoxyeicosatrienoic acid; Ischemia reperfusion; K+ channels; QTc interval; ST elevation (STE)

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; 14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; CLAMIKALANT; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHROME P450 2J2; ENZYME; EPOXYICOSATRIENOIC ACID; GLIBENCLAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CELL MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; ELECTRODE; EX VIVO STUDY; FEMALE; HEART; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART REPOLARIZATION; HEART RIGHT ATRIUM; ISOLATED HEART; MALE; MOUSE; NONHUMAN; PRESSURE; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; QT PROLONGATION; ST SEGMENT ELEVATION; TRANSGENIC MOUSE; WILD TYPE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; ELECTROCARDIOGRAPHY; ENZYME INHIBITORS; HEART; HUMANS; ISCHEMIA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; POTASSIUM; REPERFUSION INJURY;

MUS; MUS MUSCULUS;

EID: 57149086269     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.09.711     Document Type: Article

References (51)

1. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114 1 (2006) 82-96 Jul 4
2. Cinca J., Figueras J., Tenorio L., Valle V., Trenchs J., Segura R., et al. Time course and rate dependence of Q-T interval changes during noncomplicated acute transmural myocardial infarction in human beings. Am. J. Cardiol. 48 6 (1981) 1023-1028 Dec
3. Kenigsberg D.N., Khanal S., Kowalski M., and Krishnan S.C. Prolongation of the QTc interval is seen uniformly during early transmural ischemia. J. Am. Coll. Cardiol. 49 12 (2007) 1299-1305 Mar 27
4. Kleber A.G., Janse M.J., van Capelle F.J., and Durrer D. Mechanism and time course of S-T and T-Q segment changes during acute regional myocardial ischemia in the pig heart determined by extracellular and intracellular recordings. Circ. Res. 42 5 (1978) 603-613 May
5. Janse M.J. Electrophysiology and electrocardiology of acute myocardial ischemia. Can. J. Cardiol. Suppl A (1986 Jul) 46A-52A
6. Davey P. QT interval and mortality from coronary artery disease. Prog. Cardiovasc. Dis. 42 5 (2000) 359-384 Mar-Apr
7. Taylor G.J., Crampton R.S., Gibson R.S., Stebbins P.T., Waldman M.T., and Beller G.A. Prolonged QT interval at onset of acute myocardial infarction in predicting early phase ventricular tachycardia. Am. Heart J. 102 1 (1981) 16-24 Jul
8. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82 1 (2002) 131-185 Jan
9. Spector A.A., Fang X., Snyder G.D., and Weintraub N.L. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog. Lipid Res. 43 1 (2004) 55-90 Jan
10. Zeldin D.C., DuBois R.N., Falck J.R., and Capdevila J.H. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch. Biochem. Biophys. 322 1 (1995) 76-86 Sep 10
11. Seubert J., Yang B., Bradbury J.A., Graves J., Degraff L.M., Gabel S., et al. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. Circ. Res. 95 5 (2004) 506-514 Sep 3
12. Lu T., Hoshi T., Weintraub N.L., Spector A.A., and Lee H.C. Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes. J. Physiol. 537 Pt 3 (2001) 811-827 Dec 15
13. Lu T., VanRollins M., and Lee H.C. Stereospecific activation of cardiac ATP-sensitive K(+) channels by epoxyeicosatrienoic acids: a structural determinant study. Mol. Pharmacol. 62 5 (2002) 1076-1083 Nov
14. Lu T., Ye D., Wang X., Seubert J.M., Graves J.P., Bradbury J.A., et al. Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms. J. Physiol. 575 Pt 2 (2006) 627-644 Sep 1
15. Lee H.C., Lu T., Weintraub N.L., VanRollins M., Spector A.A., and Shibata E.F. Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes. J. Physiol. 519 Pt 1 (1999) 153-168 Aug 15
16. Xiao Y.F., Huang L., and Morgan J.P. Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cells. J. Physiol. 508 Pt 3 (1998) 777-792 May 1
17. Xiao Y.F., Ke Q., Seubert J.M., Bradbury J.A., Graves J., Degraff L.M., et al. Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2. Mol. Pharmacol. 66 6 (2004) 1607-1616 Dec
18. Ke Q., Xiao Y.F., Bradbury J.A., Graves J.P., Degraff L.M., Seubert J.M., et al. Electrophysiological properties of cardiomyocytes isolated from CYP2J2 transgenic mice. Mol Pharmacol. 72 4 (2007) 1063-1073 Oct
19. Seubert J.M., Sinal C.J., Graves J., DeGraff L.M., Bradbury J.A., Lee C.R., et al. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ. Res. 99 4 (2006) 442-450 Aug 18
20. Seubert J.M., Zeldin D.C., Nithipatikom K., and Gross G.J. Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury. Prostaglandins Other Lipid Mediat. 82 1-4 (2007) 50-59 Jan
21. Tosaka T., Casimiro M.C., Rong Q., Tella S., Oh M., Katchman A.N., et al. Nicotine induces a long QT phenotype in Kcnq1-deficient mouse hearts. J. Pharmacol. Exp. Ther. 306 3 (2003) 980-987 Sep
22. Stark G., Stark U., and Tritthart H.A. Modulation of cardiac impulse generation and conduction by nifedipine and verapamil analyzed by a refined surface ECG technique in Langendorff perfused guinea pig hearts. Basic Res. Cardiol. 83 2 (1988) 202-212 Mar-Apr
23. Boutjdir M., Chen L., Zhang Z.H., Tseng C.E., El-Sherif N., and Buyon J.P. Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model. Pediatr. Res. 44 1 (1998) 11-19 Jul
24. Festa A., D'Agostino Jr. R., Rautaharju P., O'Leary D.H., Rewers M., Mykkanen L., et al. Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 30 8 (1999) 1566-1571 Aug
25. Wesche D.L., Schuster B.G., Wang W.X., and Woosley R.L. Mechanism of cardiotoxicity of halofantrine. Clin. Pharmacol. Ther. 67 5 (2000) 521-529 May
26. White N.J. Cardiotoxicity of antimalarial drugs. Lancet Infect. Dis. 7 8 (2007) 549-558 Aug
27. Spector D.L., Goldman R.D., and Leinwand L.A. Cells: a laboratory manual (1998), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
28. Beene D.L., and Scott J.D. A-kinase anchoring proteins take shape. Curr. Opin. Cell Biol. 19 2 (2007) 192-198 Apr
29. Xiao Y.F. Cyclic AMP-dependent modulation of cardiac L-type Ca2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids. Prostaglandins Other Lipid Mediat. 82 1-4 (2007) 11-18 Jan
30. Nithipatikom K., Moore J.M., Isbell M.A., Falck J.R., and Gross G.J. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 291 2 (2006) H537-542 Aug
31. Moffat M.P., Ward C.A., Bend J.R., Mock T., Farhangkhoee P., and Karmazyn M. Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes. Am. J. Physiol. 264 4 Pt 2 (1993) H1154-1160 Apr
32. Gross E.R., Nithipatikom K., Hsu A.K., Peart J.N., Falck J.R., Campbell W.B., et al. Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel. J. Mol. Cell. Cardiol. 37 6 (2004) 1245-1249 Dec
33. Nithipatikom K., Gross E.R., Endsley M.P., Moore J.M., Isbell M.A., Falck J.R., et al. Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway. Circ. Res. 95 8 (2004) e65-71 Oct 15
34. Nithipatikom K., Endsley M.P., Moore J.M., Isbell M.A., Falck J.R., Campbell W.B., et al. Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection. Am. J. Physiol. Heart Circ. Physiol. 290 2 (2006) H500-505 Feb
35. Wu S., Moomaw C.R., Tomer K.B., Falck J.R., and Zeldin D.C. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J. Biol. Chem. 271 7 (1996) 3460-3468 Feb 16
36. Wu S., Chen W., Murphy E., Gabel S., Tomer K.B., Foley J., et al. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J. Biol. Chem. 272 19 (1997) 12551-12559 May 9
37. Monti J., Fischer J., Paskas S., Heinig M., Schulz H., Gosele C., et al. Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease. Nat. Genet. 40 5 (2008) 529-537 May
38. Gross G.J., Gauthier K.M., Moore J., Falck J.R., Hammock B.D., Campbell W.B., et al. Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart. Am. J. Physiol. Heart Circ. Physiol. 294 6 (2008) H2838-H2844 Jun
39. Gross G.J., Hsu A., Falck J.R., and Nithipatikom K. Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts. J. Mol. Cell. Cardiol. 42 3 (2007) 687-691 Mar
40. Higham P.D., Furniss S.S., and Campbell R.W. QT dispersion and components of the QT interval in ischaemia and infarction. Br. Heart J. 73 1 (1995) 32-36 Jan
41. Sporton S.C., Taggart P., Sutton P.M., Walker J.M., and Hardman S.M. Acute ischaemia: a dynamic influence on QT dispersion. Lancet 349 9048 (1997) 306-309 Feb 1
42. Janse M.J. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc. Res. 61 2 (2004) 208-217 Feb 1
43. Shivkumar K., Deutsch N.A., Lamp S.T., Khuu K., Goldhaber J.I., and Weiss J.N. Mechanism of hypoxic K loss in rabbit ventricle. J. Clin. Invest. 100 7 (1997) 1782-1788 Oct 1
44. Cascio W.E., Yan G.X., and Kleber A.G. Passive electrical properties, mechanical activity, and extracellular potassium in arterially perfused and ischemic rabbit ventricular muscle. Effects of calcium entry blockade or hypocalcemia. Circ. Res. 66 6 (1990) 1461-1473 Jun
45. Bethell H.W., Vandenberg J.I., Smith G.A., and Grace A.A. Changes in ventricular repolarization during acidosis and low-flow ischemia. Am. J. Physiol. 275 2 Pt 2 (1998) H551-561 Aug
46. Gross E.R., Peart J.N., Hsu A.K., Grover G.J., and Gross G.J. K(ATP) opener-induced delayed cardioprotection: involvement of sarcolemmal and mitochondrial K(ATP) channels, free radicals and MEK1/2. J. Mol. Cell. Cardiol. 35 8 (2003) 985-992 Aug
47. Suzuki M., Sasaki N., Miki T., Sakamoto N., Ohmoto-Sekine Y., Tamagawa M., et al. Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J. Clin. Invest. 109 4 (2002) 509-516 Feb
48. Gross G.J., and Fryer R.M. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ. Res. 84 9 (1999) 973-979 May 14
49. Seino S., and Miki T. Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog. Biophys. Mol. Biol. 81 2 (2003) 133-176 Feb
50. Gauthier K.M., Deeter C., Krishna U.M., Reddy Y.K., Bondlela M., Falck J.R., et al. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ. Res. 90 9 (2002) 1028-1036 May 17
51. Marinovic J., Ljubkovic M., Stadnicka A., Bosnjak Z.J., and Bienengraeber M. Role of sarcolemmal ATP-sensitive potassium channel in oxidative stress-induced apoptosis: mitochondrial connection. Am. J. Physiol. Heart Circ. Physiol. 294 3 (2008) H1317-H1325 Mar